Target TSH Level in Primary Hypothyroidism
For adults under 65 years with primary hypothyroidism, target TSH should be within the normal reference range of 0.45-4.12 mIU/L, while maintaining TSH above 1 mIU/L to avoid overtreatment risks. For patients 65 years and older, use age-adjusted upper limits: approximately 7 mIU/L for ages 70-79 years and 8 mIU/L for those over 80 years 1.
General Adult Population (Under 65 Years)
The therapeutic target for most adults is straightforward: aim for TSH within the standard reference range of 0.45-4.12 mIU/L based on NHANES III data 2. However, there's an important safety floor—always maintain TSH above 1 mIU/L to prevent complications from overtreatment 2.
Why This Range Matters
The evidence clearly shows that overtreatment carries significant risks:
- Cardiovascular complications, particularly atrial fibrillation in elderly patients 2
- Accelerated bone loss in postmenopausal women 2
- Affective disturbances 2
Approximately 20% of patients on thyroid hormone are overtreated 2, making this lower boundary of TSH >1 mIU/L a critical safety parameter.
Controversy About Lower Targets
While some have proposed targeting TSH to 2.5-3.0 mIU/L as the upper limit, the guidelines explicitly reject this approach 2. The reasoning is compelling: TSH naturally varies up to 50% above and below an individual's mean on any given day. Using a lower cutoff of 2.5 mIU/L would misclassify millions of euthyroid patients as hypothyroid without clear clinical benefit 2.
Elderly Patients (65 Years and Older)
The target TSH range fundamentally changes with age, and this is where many clinicians make critical errors. The 2020 French Endocrine Society guidelines provide the most specific age-adjusted targets 1:
Age-Specific Upper Limits
- Ages 70-79 years: Upper limit of normal is 7 mIU/L 1
- Ages 80+ years: Upper limit of normal is 8 mIU/L 1
- Practical rule: Consider using "age divided by 10" as the upper TSH target for very elderly patients 1
Critical Safety Floor Remains
Even in elderly patients, maintain TSH above 1 mIU/L to prevent thyrotoxicosis, which occurs in 20-50% of overtreated elderly patients and carries serious cardiac and bone consequences 1.
Why Age-Adjusted Targets Are Essential
Recent research confirms that TSH naturally increases with age 3, 4, 5. Using standard adult reference ranges in elderly patients leads to:
- Overdiagnosis of subclinical hypothyroidism: Up to 48.5% of elderly patients labeled as having subclinical hypothyroidism would be reclassified as normal using age-specific ranges 4
- Potential harm from treatment: Evidence suggests treating subclinical hypothyroidism may actually be harmful in elderly patients 3
- Unnecessary treatment: Many elderly patients with mildly elevated TSH (by standard ranges) recover spontaneously without intervention 3, 6
Monitoring Strategy
Use TSH alone for monitoring primary hypothyroidism 1. Free T4 is not sufficiently specific as a therapeutic endpoint 2.
Timing of Checks
- Initial dose adjustment: Check TSH 6 weeks to 3 months after starting or changing dose 1
- Once stable: Annual checks are sufficient 1
- After medication interactions: Recheck 6-8 weeks after introducing or stopping drugs affecting levothyroxine bioavailability 1
Common Pitfalls to Avoid
Using the same TSH target for all ages: This leads to overtreatment in elderly patients with increased cardiovascular and skeletal risks 1
Targeting TSH below 1 mIU/L: This substantially increases risk of atrial fibrillation and bone loss, particularly in vulnerable populations 2, 1
Treating based on a single elevated TSH: In subclinical hypothyroidism, 62% of elevated TSH values revert to normal spontaneously—always confirm with repeat testing at least 2 months later 3
Ignoring age-specific physiology: TSH reference intervals naturally broaden with age, with the 97.5th percentile increasing from 3.6 mIU/L in patients under 40 to 7.5 mIU/L in patients over 80 3, 4, 5